Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis…

Overview of attention for article published in Osteoporosis International, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 207 Dimensions

Readers on

mendeley: 168 Mendeley
citeulike: 2 CiteULike

Summary Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Safety and efficacy issues

Cited by World Health Organization on 25 Feb 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO Drug Information 2013, vol. 27, 2 [‎full issue]‎

Cited by World Health Organization on 24 Feb 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Bisphosphonates for treating osteoporosis: Committee papers

Cited by National Institute for Health and Care Excellence on 03 Jul 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.